Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 17

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 17
---
 may not have access to certain information they deem important. The Company cannot predict if investors will find Company Shares less attractive because it expects to rely on these exemptions. If some investors find Company Shares less attractive as a result, there may be a less active trading market and the price for Company Shares may be more volatile. The Company may not qualify as an emerging growth company in the future and may incur increased legal, accounting and compliance costs associated with Section 404 of the Sarbanes -OxleyAct or other matters as a result. The Company will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the Closing, (b) in which it has total annual gross revenue of at least $1.235 billion, or (c) in which it is deemed to be a large accelerated filer, which means the aggregate worldwide market value of Company Shares that are held by non -affiliatesequals or exceeds $700 million as of the prior June 30 th, and (2) the date on which it has issued more than $1.0 billion in non -convertibledebt during the prior three -yearperiod. APx is not required to and did not obtain a fairness opinion in connection with the Business Combination. APx Shareholders are therefore relying on the judgment of the APx Board, and you will not have assurance from an independent source that the consideration APx is paying for the Company is fair to APx from a financial point of view. While the Closing is not conditioned upon the consummation of additional financing, the Company is currently undertaking discussions with third parties regarding additional equity or equity -linkedfinancing to support the Company’s operations following the Closing. While the Initial Shareholders do not intend to participate in such third -partyfinancing, additional financing may not be available in amounts or on terms satisfactory to the Company or at all. On February 27, 2023, APx held an extraordinary general meeting (the “February 2023 EGM”) and its shareholders approved an amendment to its amended and restated memorandum and articles of association (as amended, the “Articles of Association”) and to the investment management trust agreement dated as of September 7, 2021 (as amended, the “Trust Agreement”) to change the payment required to extend the combination period by two three -monthperiods. In connection with such vote, the holders of 10,693,417 public shares properly exercised their right to